Sanofi (SNY) Invested Capital (2009 - 2025)

Sanofi has disclosed Invested Capital across 17 years of filings, most recently posting $104.9 billion for Q4 2025.

• Invested Capital for Q4 2025 came in at $104.9 billion, up 4.78% year-over-year; the trailing twelve-month figure through Dec 2025 was $104.9 billion (up 4.78% YoY), and the FY2025 annual result was $104.9 billion, up 4.78% from the prior year.
• Invested Capital came in at $104.9 billion for Q4 2025 at Sanofi, up from $87.8 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $104.9 billion in Q4 2025 to a low of $78.8 billion in Q2 2021.
• The 5-year median for Invested Capital is $92.2 billion (2022), against an average of $91.9 billion.
• Across the five-year window, Invested Capital advanced 7.12% in 2021 and fell 5.73% in 2022, its largest moves.
• Sanofi's Invested Capital stood at $101.7 billion in 2021, then decreased by 5.73% to $95.9 billion in 2022, then increased by 1.61% to $97.4 billion in 2023, then increased by 2.69% to $100.1 billion in 2024, then rose by 4.78% to $104.9 billion in 2025.
• The last three Invested Capital figures came in at $104.9 billion (Q4 2025), $87.8 billion (Q2 2025), and $100.1 billion (Q4 2024), per Business Quant data.